The global Fertility Test Market was valued at USD 7.14 billion in 2024 and is estimated at USD 7.69 billion in 2025. It is projected to reach USD 15.22 billion by 2034, growing at a CAGR of 7.88% from 2025 to 2034. North America was the largest regional market in 2024. Fertility testing solutions give individuals insights into reproductive health, including ovulation tracking, hormone monitoring, and sperm analysis, through self-testing kits, laboratory tests, and digital platforms integrated with mobile apps and data analytics.
Ovulation Prediction Kits Lead the Product Landscape
By product, the market includes ovulation prediction kits, fertility monitors, and male fertility testing products. Ovulation prediction kits led the market in 2024 owing to widespread consumer interest in monitoring fertility at home. Awareness of precise ovulation tracking and compatibility with mobile applications further strengthens their use among reproductive-age women worldwide. The fertility monitors category is segmented into urine-based, saliva-based, and other monitors.
Male Fertility Testing Gains Momentum
Male fertility testing is expected to register the highest CAGR among products through the forecast period as a result of growing male infertility issues and enhanced availability of home-based sperm test kits. Technology improvements are also increasing test convenience and accuracy. By application, female fertility testing dominated in 2024 because of rising demand for ovulation and hormonal evaluation solutions, while the male segment is anticipated to expand at the highest CAGR amid rising instances of male infertility and elevated awareness about sperm health.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/fertility-test-market
Home Testing and Purchase Models
Consumers are embracing in-home testing for convenience, privacy, and timely care, and growing adoption of home fertility tests reflects that preference. The home care settings segment led by end user in 2024, and integration with mobile applications and wearable devices improves usability and supports penetration in urban areas. By mode of purchase, direct/prescription products led in 2024 because of clinical reliability and advice from healthcare providers, while online products are expected to expand at the highest CAGR on the back of e-commerce adoption and demand for discreet, home-delivered conception kits.
Recent Industry Developments
Recent activity shows the direction of innovation. In October 2025, Sapyen launched the UK’s first at-home male fertility test kit, allowing men to collect samples at home and receive lab-verified results in days. In August 2025, Maven Clinic launched a cycle tracker and at-home male fertility tools to give people earlier, personalized guidance when trying to conceive. Also in October 2025, Genie Fertility raised USD 1.2 million to develop a non-invasive fertility test that uses menstrual blood to provide more accurate reproductive health insights.
Competitive Landscape
The market is moderately competitive, with organizations improving home and clinical test solutions through AI-driven monitoring, digitalization, and enhanced hormone and ovulation detection technologies. Collaboration with fertility clinics, e-commerce sites, and healthcare operators also enhances market access, scalability, and consumer adoption worldwide.
Segmentation and Cost Considerations
The report segments the market by product, mode of purchase, application, end user, and region, giving suppliers a structured view of where demand is concentrated. Hospitals and clinics are projected to expand with the highest CAGR by end user, fueled by mounting need for clinical-grade tests and remote monitoring. High cost of testing and limited insurance reimbursement continue to be major hurdles to market growth.
Key Players in the Fertility Test Market
Some of the major players operating in the global market include:
- Abbott Laboratories
- Babystart Ltd
- Church & Dwight Co., Inc.
- Fairhaven Health LLC
- Fertility Focus Limited
- Geratherm Medical AG
- HiLin Life Products
- Laboratory Corporation of America Holdings
- Prestige Brands Holdings Inc.
- Quidel Corporation
- Swiss Precision Diagnostics GmbH
- UEBE Medical GmbH
Conclusion
The Fertility Test Market is moving toward convenient, digitally connected products. Ovulation prediction kits lead, male-focused testing is expected to grow fastest by product, and home-based formats continue to gain traction. For B2B stakeholders, product accuracy, mobile integration, and flexible purchase models will be central as the market advances from USD 7.69 billion in 2025 toward USD 15.22 billion by 2034 at a CAGR of 7.88%.
More Trending Latest Reports By Polaris Market Research:
Gynecological Examination Chairs Market
Enterprise Content Management Market
AI Trust, Risk and Security Management Market